Robert Hofmeister

Robert Hofmeister

Director/Board Member at ALAUNOS THERAPEUTICS, INC.

Net worth: - $ as of 30/03/2024

56 year
Health Technology
Consumer Services
Consumer Non-Durables

Profile

Robert Hofmeister is an Independent Director at Alaunos Therapeutics, Inc. and a Co-Managing Director at Molkerei Hainichen Freiberg GmbH & Co. KG.
He was previously the Global Head-Translational Immunotherapy at EMD Serono Research & Development Institute, Inc. from 2012 to 2015 and the Senior Vice President-Research & Development at TCR2 Therapeutics, Inc. from 2015 to 2022.
He holds a doctorate degree from the University of Regensburg.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
05/06/2023 0 ( -.--% ) - $ 30/03/2024

Robert Hofmeister active positions

CompaniesPositionStart
ALAUNOS THERAPEUTICS, INC. Director/Board Member 29/03/2023
Chief Executive Officer -
All active positions of Robert Hofmeister

Former positions of Robert Hofmeister

CompaniesPositionEnd
TCR2 THERAPEUTICS INC. Chief Tech/Sci/R&D Officer 28/02/2022
EMD Serono Research & Development Institute, Inc. Corporate Officer/Principal 31/12/2014
See the detail of Robert Hofmeister's experience

Training of Robert Hofmeister

University of Regensburg Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert Hofmeister's experience

Connections

43

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
ALAUNOS THERAPEUTICS, INC.

Health Technology

Private companies3
EMD Serono Research & Development Institute, Inc.

Health Technology

Consumer Non-Durables

See company connections
  1. Stock Market
  2. Insiders
  3. Robert Hofmeister